Evidence map›Paper›PMID 28808001›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2017

Two transmembrane dimers of the bovine papillomavirus E5 oncoprotein clamp the PDGF β receptor in an active dimeric conformation.

Alexander G Karabadzhak, Lisa M Petti, Francisco N Barrera, Anne P B Edwards, Andrés Moya-Rodríguez, Yury S Polikanov, J Alfredo Freites, Douglas J Tobias, Donald M Engelman, Daniel DiMaio

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 33 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Heliyon · 2024
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Frontiers in veterinary science · 2021
    Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Alexander G KarabadzhakDepartment of Molecular Biophysics & Biochemistry, Yale University, New Haven, CT 06520-8024.
Lisa M PettiDepartment of Genetics, Yale School of Medicine, New Haven, CT 06520-8005.
Francisco N BarreraDepartment of Biochemistry and Cellular and Molecular Biology, University of Tennessee, Knoxville, TN 37996-0800.ORCID 0000-0002-5200-7891
Anne P B EdwardsDepartment of Genetics, Yale School of Medicine, New Haven, CT 06520-8005.
Andrés Moya-RodríguezDepartment of Genetics, Yale School of Medicine, New Haven, CT 06520-8005.
Yury S PolikanovDepartment of Molecular Biophysics & Biochemistry, Yale University, New Haven, CT 06520-8024.
J Alfredo FreitesDepartment of Chemistry, University of California, Irvine, CA 92697-2025.
Douglas J TobiasDepartment of Chemistry, University of California, Irvine, CA 92697-2025.
Donald M EngelmanDepartment of Molecular Biophysics & Biochemistry, Yale University, New Haven, CT 06520-8024; daniel.dimaio@yale.edu donald.engelman@yale.edu.
Daniel DiMaioDepartment of Molecular Biophysics & Biochemistry, Yale University, New Haven, CT 06520-8024; daniel.dimaio@yale.edu donald.engelman@yale.edu.
Yale University · USUniversity of California, Irvine · USYale Cancer Center · USUniversity of Tennessee at Knoxville · US

Funding

CELL TRANSFORMATION BY BOVINE PAPILLOMAVIRUSR01CA037157 · NCI · YALE UNIVERSITY · PI DIMAIO, DANIEL C. · 1985 to 2019
$9.9M
TM INTERACTIONS IN MEMBRANE PROTEIN FOLDING AND FUNCTIONR01GM073857 · NIGMS · YALE UNIVERSITY · PI ANDREEV, OLEG A, ENGELMAN, DONALD M. · 2006 to 2023
$8.4M
Transmembrane Peptides for Targeting Acidosis - Equipment SupplementR01GM120642 · NIGMS · UNIVERSITY OF TENNESSEE KNOXVILLE · PI BARRERA, FRANCISCO NICOLAS · 2016 to 2020
$1.7M
CELL TRANSFORMATION BY BOVINE PAPILLOMAVIRUSR37CA037157 · NCI · YALE UNIVERSITY · PI DIMAIO, DANIEL · 1992 to 1999
–
NCI NIH HHS R01 CA037157NCI NIH HHS R37 CA037157NIGMS NIH HHS R01 GM073857NIGMS NIH HHS R01 GM120642
6 · The paper itself

Abstract

The dimeric 44-residue E5 protein of bovine papillomavirus is the smallest known naturally occurring oncoprotein. This transmembrane protein binds to the transmembrane domain (TMD) of the platelet-derived growth factor β receptor (PDGFβR), causing dimerization and activation of the receptor. Here, we use Rosetta membrane modeling and all-atom molecular dynamics simulations in a membrane environment to develop a chemically detailed model of the E5 protein/PDGFβR complex. In this model, an active dimer of the PDGFβR TMD is sandwiched between two dimers of the E5 protein. Biochemical experiments showed that the major PDGFβR TMD complex in mouse cells contains two E5 dimers and that binding the PDGFβR TMD to the E5 protein is necessary and sufficient to recruit both E5 dimers into the complex. These results demonstrate how E5 binding induces receptor dimerization and define a molecular mechanism of receptor activation based on specific interactions between TMDs.

Indexed as

Amino Acid SequenceAnimalsCattleCell LineCell Transformation, ViralDimerizationHumansMembrane ProteinsMiceMolecular ConformationOncogene Proteins, ViralPapillomaviridaePapillomavirus InfectionsProtein MultimerizationReceptor, Platelet-Derived Growth Factor betaMembrane Proteinsoncogene protein E5, Bovine papillomavirus type 1Oncogene Proteins, ViralReceptor, Platelet-Derived Growth Factor betablue native gel electrophoresisBPVoncogenetransmembrane protein complextraptamer

Identifiers

PMID28808001
PMCPMC5584431
OpenAlexW2748606161

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.